Table 1. Microbiological etiologies and baseline characteristics of study group.
| Gender | Age (years) | Underlying disease | Bacteria |
|---|---|---|---|
| M | 72 | Parkinson disease | – |
| F | 68 | – | – |
| M | 89 | COPD, CHD | – |
| M | 50 | AS, gastric ulcer | – |
| F | 76 | Bronchiectasis, cerebrovascular disease, CKD, RA | – |
| F | 53 | Liver disease, DM | – |
| M | 66 | – | – |
| F | 64 | – | – |
| M | 59 | – | – |
| M | 66 | – | – |
| M | 85 | COPD, cerebrovascular disease, tumor | – |
| M | 18 | – | – |
| M | 72 | HBP | Streptococcus pneumoniae |
| M | 35 | – | Streptococcus pneumoniae |
| M | 80 | Liver disease | Klebsiella pneumoniae |
| M | 59 | Cerebrovascular disease | Klebsiella pneumoniae, Haemophilus influenzae |
| M | 24 | Myasthenia gravis | Stenotrophomonas maltophilia |
| M | 22 | Myodystrophia | Klebsiella pneumoniae, Mycoplasma pneumoniae |
| F | 28 | – | Mycoplasma pneumoniae |
| M | 55 | HBP | Streptococcus pneumoniae |
F, female; M, men; COPD, chronic obstructive pulmonary disease; AS, ankylosing spondylitis; CKD, chronic kidney disease; DM, diabetes mellitus; HBP, hypertension; RA, rheumatoid arthritis; CHD, coronary heart disease.